289 related articles for article (PubMed ID: 19135315)
21. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
[TBL] [Abstract][Full Text] [Related]
22. Effects of radiation on hearing in patients with malignancies of head and neck.
Balraj A; Raman R; Rangad F
Singapore Med J; 1992 Oct; 33(5):481-3. PubMed ID: 1455273
[TBL] [Abstract][Full Text] [Related]
23. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
24. Long-term hearing loss after chemoradiation in patients with head and neck cancer.
Theunissen EA; Zuur CL; Bosma SC; Lopez-Yurda M; Hauptmann M; van der Baan S; de Boer JP; van der Molen L; Rasch CR; Dreschler WA; Balm AJ
Laryngoscope; 2014 Dec; 124(12):2720-5. PubMed ID: 24964759
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002.
Agrawal Y; Platz EA; Niparko JK
Otol Neurotol; 2009 Feb; 30(2):139-45. PubMed ID: 19092714
[TBL] [Abstract][Full Text] [Related]
26. Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy.
Schultz C; Goffi-Gomez MV; Pecora Liberman PH; Pellizzon AC; Carvalho AL
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1065-9. PubMed ID: 21079158
[TBL] [Abstract][Full Text] [Related]
27. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.
Monroe AT; Reddy SC; Gibbs GL; White GA; Peddada AV
Radiother Oncol; 2008 May; 87(2):188-94. PubMed ID: 18237801
[TBL] [Abstract][Full Text] [Related]
29. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
30. The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study.
Cruickshanks KJ; Tweed TS; Wiley TL; Klein BE; Klein R; Chappell R; Nondahl DM; Dalton DS
Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1041-6. PubMed ID: 14568784
[TBL] [Abstract][Full Text] [Related]
31. Investigation of hearing loss in patients with acute brucellosis by standard and high-frequency audiometry.
Kaygusuz TO; Kaygusuz I; Kilic SS; Yalcin S; Felek S
Clin Microbiol Infect; 2005 Jul; 11(7):559-63. PubMed ID: 15966974
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced oscillopsia in nasopharyngeal carcinoma patients.
Chen PR; Hsu LP; Tu CE; Young YH
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):466-70. PubMed ID: 15667968
[TBL] [Abstract][Full Text] [Related]
33. Hearing thresholds among young professional divers: a 6-year longitudinal study.
Skogstad M; Haldorsen T; Arnesen AR; Kjuus H
Aviat Space Environ Med; 2005 Apr; 76(4):366-9. PubMed ID: 15828636
[TBL] [Abstract][Full Text] [Related]
34. Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy.
Dobie RA; Black FO; Pezsnecker SC; Stallings VL
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):253-7. PubMed ID: 16549744
[TBL] [Abstract][Full Text] [Related]
35. No hearing loss after repeated courses of tobramycin in cystic fibrosis patients.
Scheenstra RJ; Heijerman HG; Zuur CL; Touw DJ; Rijntjes E
Acta Otolaryngol; 2010 Feb; 130(2):253-8. PubMed ID: 19479457
[TBL] [Abstract][Full Text] [Related]
36. Pure-tone threshold description of an elderly French screened population.
Blanchet C; Pommie C; Mondain M; Berr C; Hillaire D; Puel JL
Otol Neurotol; 2008 Jun; 29(4):432-40. PubMed ID: 18520580
[TBL] [Abstract][Full Text] [Related]
37. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients.
Jereczek-Fossa BA; Santoro L; Alterio D; Franchi B; Fiore MR; Fossati P; Kowalczyk A; Canino P; Ansarin M; Orecchia R
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):403-15. PubMed ID: 17398020
[TBL] [Abstract][Full Text] [Related]
38. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.
van der Putten L; de Bree R; Plukker JT; Langendijk JA; Smits C; Burlage FR; Leemans CR
Head Neck; 2006 Oct; 28(10):902-8. PubMed ID: 16783830
[TBL] [Abstract][Full Text] [Related]
39. Long-term hearing results in gamma knife radiosurgery for acoustic neuromas.
Bush ML; Shinn JB; Young AB; Jones RO
Laryngoscope; 2008 Jun; 118(6):1019-22. PubMed ID: 18364592
[TBL] [Abstract][Full Text] [Related]
40. Vibrant Soundbridge for hearing restoration after chronic ear surgery.
Streitberger C; Perotti M; Beltrame MA; Giarbini N
Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):83-8. PubMed ID: 19813469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
